Assessment of parents’ preferences for the treatment of school-age children with ADHD: a discrete choice experiment

Fegert, Jörg M.; Slawik, Lara; Wermelskirchen, Detlef; Nübling, Matthias; Mühlbacher, Axel

doi:10.1586/erp.11.22

Cited by 24 publications

(25 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several strands of evidence suggest that medication adherence may be improved by tailoring the selection of drug to an individual patient. Discrete choice experiments suggest that long-acting stimulants, with consistent therapeutic coverage throughout the day, are the preferred stimulant formulations of most patients [20, 42, 58, 64], and retrospective claims analyses suggest that long-acting stimulants are generally associated with enhanced adherence and persistence in patients of all ages compared with short-acting stimulants [20, 59, 80, 83]. In addition to drug regimens that patients find convenient, other strategies to improve adherence include improved communication between physicians, caregivers, and patients; clear instruction and encouragement; peer support groups; advice about reminders to take medication and incorporating medication into daily routines; and the use of positive reinforcement to improve attitudes to medication [66].…”

Section: Optimizing Medication For An Individualmentioning

confidence: 99%

Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options

Hodgkins

Shaw

Coghill

et al. 2012

Eur Child Adolesc Psychiatry

128

View full text Add to dashboard Cite

Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders among school-aged children. It is highly symptomatic and associated with significant impairment. This review examines the role of stimulant medications in the treatment of children and adolescents with ADHD. Published clinical studies that compared methylphenidate- and amfetamine-based stimulants in children and adolescents with ADHD support the therapeutic utility of stimulant treatments, and suggest robust efficacy and acceptable safety outcomes in groups treated with either stimulant. Evidence-based guidelines agree that each patient with ADHD is unique and individual treatment strategies that incorporate both drug and non-drug treatment options should be sought. In seeking to optimize individual response and outcomes to stimulant therapy, important considerations include the selection of stimulant class, the choice of long- or short-acting stimulant formulations, addressing effectively any emergent adverse effects and strategies aimed at enhancing adherence to dosing regimen and persistence on therapy.

show abstract

Section: Optimizing Medication For An Individualmentioning

confidence: 99%

Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options

Hodgkins

Shaw

Coghill

et al. 2012

Eur Child Adolesc Psychiatry

128

View full text Add to dashboard Cite

show abstract

“…While previous studies have examined preferences for ADHD treatment, most of them tend to focus only on pharmacological treatment and behavioral therapy [18–20, 56]. This study also examined preferences for school accommodation, provider specialty, and caregiver behavioral management training, all of which are important in care coordination in pediatric ADHD.…”

Section: Discussionmentioning

confidence: 99%

A Latent Class Analysis to Identify Variation in Caregivers’ Preferences for their Child’s Attention-Deficit/Hyperactivity Disorder Treatment: Do Stated Preferences Match Current Treatment?

Bridges

Ross

et al. 2016

Patient

View full text Add to dashboard Cite

Objectives To investigate variation in caregiver preferences for their child’s attention-deficit/hyperactivity disorder (ADHD) care and to determine if their stated preferences align with current care management. Methods Caregivers of a child aged 4–14 years and in care for ADHD were recruited from pediatric outpatient clinics and advocacy groups across the state of Maryland. Participants completed a survey collecting demographics, the child’s treatment, and caregiver preferences—elicited using a best-worst scaling experiment (case 2). Latent class analysis was used to identify distinct preference segments and bivariate analyses were used to compare the association between segment membership with what the child was currently receiving for their ADHD. Results Participants (n = 184) were predominantly White (68%) and the child’s mother (84%). Most children had ADHD for 2 or more years (79%). Caregiver preferences were distinguished by two segments: continuous medication (36%) and minimal medication (64%). The two groups had very different preferences for when medication was administered (p < 0.001), but they had similar preferences for provider oriented and non-medication interventions (p > 0.05 for the caregiver behavior training, provider communication, provider specialty, and out-of-pocket costs). One third of the sample did not receive the preferred individualized education program and 42% of the minimal medication group reported using medication 7 days a week all year round. Conclusions Although behavior management training and school accommodations aspects of an ADHD care plan are more important to caregivers than evidence-based medication, fewer families had access to educational accommodations. Further research is needed to clarify how stated preferences for care align with treatments used in actual practice settings.

show abstract

“…Nonetheless, this scoping review contributes to the identification of some important gaps in behaviour treatment recommendations in childhood ADHD clinical practice guidelines, which should be addressed in future revisions of the identified guidelines. For instance, upcoming revisions to the NICE guidelines may consider (a) discussing situations where the combination of medication and behavioural interventions might be recommended such as, situations where medication alone is not adequate and/or if parents or teachers prefer combination treatment which may influence adherence to treatment (Fegert et al., ; Glass & Wegar, ; McLeod et al., ); (b) more clearly identifying the relative strength of evidence for behavioural interventions compared to other psychosocial interventions (e.g. social skills training; Storebø et al., ) and (c) proposing a staged approach for levels of behavioural interventions.…”

Section: Discussionmentioning

confidence: 99%

“…Meanwhile, there is some evidence that teachers may prefer pharmacotherapy and behavioural interventions together rather than either of these treatments alone (Glass & Wegar, ). Parental preference is an important consideration given the influence that parental support has on adherence to treatment (Swanson, ) and clinical outcomes (Fegert, Slawik, Wermelskirchen, Nübling, & Mühlbacher, ).…”

Section: Introductionmentioning

confidence: 99%

Behavioural treatment recommendations in clinical practice guidelines for attention‐deficit/hyperactivity disorder: a scoping review

Vallerand

Kalenchuk

McLennan

2014

Child Adoles Ment Health

View full text Add to dashboard Cite

Background: The extent of behavioural treatment recommendations described in attention-deficit/hyperactivity disorder (ADHD) practice guidelines has not been examined. Method: A scoping review identified eight agency-based ADHD practice guidelines. Key components of behavioural treatment recommendations were summarized. Results: All guidelines mentioned behavioural treatment as a consideration for managing ADHD, however, the extent to which they were detailed varied. Most guidelines provided lists of behavioural techniques but with minimal specifics regarding treatment delivery. Conclusions: There is far less detailing of behavioural approaches compared to pharmacological treatments for ADHD. Greater detailing of evidencebased behavioural approaches may foster improved delivery of high-quality behaviour treatment. Key Practitioner Message• Behaviour management is one evidence-based, nonpharmacological option for the treatment of children with attention-deficit/hyperactivity disorder (ADHD).• While most ADHD clinical practice guidelines mention behaviour management as a treatment option, information is typically poorly detailed in contrast to that for pharmacological management.• New or revised guidelines ought to consider providing greater details on evidence-based behavioural treatment which may foster improved access to and delivery of higher quality behavioural treatment than may currently be offered.

show abstract

Assessment of parents’ preferences for the treatment of school-age children with ADHD: a discrete choice experiment

Cited by 24 publications

References 35 publications

Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options

Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options

A Latent Class Analysis to Identify Variation in Caregivers’ Preferences for their Child’s Attention-Deficit/Hyperactivity Disorder Treatment: Do Stated Preferences Match Current Treatment?

Behavioural treatment recommendations in clinical practice guidelines for attention‐deficit/hyperactivity disorder: a scoping review

Contact Info

Product

Resources

About